Vladislav Sandler
Founder bei HEMOGENYX PHARMACEUTICALS PLC
Vermögen: 923 538 $ am 31.03.2024
Profil
Dr. Vladislav Sandler is a Chief Executive Officer & Executive Director at HemoGenyx Pharmaceuticals Plc, an Assistant Professor at State University of New York at Downstate Medical Center, a Chief Executive Officer & Director at Hemogenyx Pharmaceuticals LLC and a Member at The International Society for Stem Cell Research.
He is on the Board of Directors at HemoGenyx Pharmaceuticals Plc, Hemogenyx Pharmaceuticals LLC and Hemogenyx UK Ltd.
He received his doctorate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2022 | 41 544 677 ( 3,10% ) | 923 538 $ | 31.03.2024 |
Aktive Positionen von Vladislav Sandler
| Unternehmen | Position | Beginn |
|---|---|---|
| HEMOGENYX PHARMACEUTICALS PLC | Founder | 01.01.2012 |
Hemogenyx Pharmaceuticals LLC
 Hemogenyx Pharmaceuticals LLC BiotechnologyHealth Technology HemoGenyx LLC operates as Biopharmaceutical Company that develops treatment for blood diseases. The company was founded by Vladislav Sandler and Alexis M. Sandler and is headquartered in Brooklyn, NY. | Founder | - |
| State University of New York at Downstate Medical Center | Corporate Officer/Principal | - |
| The International Society for Stem Cell Research | Corporate Officer/Principal | - |
Hemogenyx UK Ltd.
 Hemogenyx UK Ltd. Pharmaceuticals: MajorHealth Technology Part of HemoGenyx Pharmaceuticals Plc, Hemogenyx UK Ltd. is a pharmaceutical company founded in 2016. The private company develops pharmaceuticals and is based in London, UK. | Director/Board Member | 04.10.2017 |
Ausbildung von Vladislav Sandler
| University of British Columbia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEMOGENYX PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| The International Society for Stem Cell Research | |
Hemogenyx Pharmaceuticals LLC
Hemogenyx Pharmaceuticals LLC BiotechnologyHealth Technology HemoGenyx LLC operates as Biopharmaceutical Company that develops treatment for blood diseases. The company was founded by Vladislav Sandler and Alexis M. Sandler and is headquartered in Brooklyn, NY. | Health Technology |
Hemogenyx UK Ltd.
Hemogenyx UK Ltd. Pharmaceuticals: MajorHealth Technology Part of HemoGenyx Pharmaceuticals Plc, Hemogenyx UK Ltd. is a pharmaceutical company founded in 2016. The private company develops pharmaceuticals and is based in London, UK. | Health Technology |
